Switzerland · 
Who invested in FoRx Therapeutics?
FoRx Therapeutics's investors include Omega Funds and EQT Life Sciences.
Switzerland · Series A startup
Who invested in FoRx Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $50MDec 2025
- Investors
- 2
The rounds
- Dec 2025
Founders and team
From FoRx Therapeutics's own website: 6 on the team.
- Tarig BashirPhD – Chief Executive Officer (CEO)
- Dr. Jane DoeChief Scientific Officer
- Dr. Michael JohnsonChief Medical Officer
- Frank ZenkePhD – Chief Scientific Officer (CSO)
- Jens WürthnerMD PhD – Chief Medical Officer (CMO)
- Sarah WilliamsChief Financial Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about FoRx Therapeutics
How much has FoRx Therapeutics raised?
FoRx Therapeutics has raised $50M across 1 round since 2025.
When did FoRx Therapeutics last raise?
FoRx Therapeutics's most recent round was a Series A of $50M in Dec 2025.
What was FoRx Therapeutics's biggest round?
Its most recent round, $50M in Dec 2025, is also its largest on record.
Who backed FoRx Therapeutics first?
FoRx Therapeutics's first round on record, in Dec 2025, was backed by Omega Funds and EQT Life Sciences.
What stage is FoRx Therapeutics at?
FoRx Therapeutics's latest named round is a Series A, in Dec 2025.
Where is FoRx Therapeutics based?
FoRx Therapeutics is based in Switzerland.
Companies like FoRx Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.